Clinical Trial Update: Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]

View source ↗

Summary

This Phase 3 trial is evaluating letrozole with or without paclitaxel and carboplatin in stage II-IV ovarian, fallopian tube, or primary peritoneal cancer; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low-grade Serous Fallopian Tube Cancer
• Low-grade Serous Ovarian Cancer
• Low-grade Serous Primary Peritoneal Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Letrozole (letrozole)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: NRG Oncology | Conditions: Low Grade Fallopian Tube Serous Adenocarcinoma, Ovarian Low Grade Serous Adenocarcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING